First Line Treatment Trial in Multiple Myeloma, Finnish Myeloma Group- Multiple Myeloma 02
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Filgrastim
Related studies linked through entity extraction aliases.
Donor Natural Killer Cells in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Haploidentical Stem Cell Transplantation for Children With Acquired Severe Aplastic Anemia
- Status
- UNKNOWN
- Phase
- PHASE2
CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Heparin Binding Protein in Patients With Acute Respiratory Failure Treated With GCSF (Filgrastim)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Expanded Cord Blood Cell Infusion Following Combination Chemotherapy in Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Busulfan and Cyclophosphamide Followed By ALLO BMT
- Status
- TERMINATED
- Phase
- NA
Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Allogeneic Stem Cell Transplant for CLL
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- PHASE2
Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Improving White Blood Cell Collection From Healthy Donors
- Status
- RECRUITING
- Phase
- PHASE4
Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Filgrastim (G-CSF)Produced by Blausiegel Indústria e Comércio Ltda. Compared to Granulokine Produced by Produtos Roche Químicos e Farmacêuticos S/A.
- Status
- COMPLETED
- Phase
- PHASE1
Collection of Transplant Stem Cells for Plasma Cell Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Lymphocyte Reconstitution After Administration of Pegfilgrastim Versus Filgrastim After Peripheral Stem Cell Transplantation
- Status
- TERMINATED
- Phase
- NA
Filgrastim in Treating Patients With Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery
- Status
- TERMINATED
- Phase
- PHASE3
Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers
- Status
- COMPLETED
- Phase
- PHASE2